 |
Cost-Benefit Analysis
Research News and Information
Definition of 'Cost-Benefit Analysis'A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results. Common names: Cost-Benefit Analysis; Analyses, Cost-Benefit; Analysis, Cost-Benefit; Cost-Benefit Analyses; Cost Benefit Analysis; Analyses, Cost Benefit; Analysis, Cost Benefit; Cost Benefit Analyses; Cost Effectiveness; Effectiveness, Cost; Cost-Benefit Data; Cost Benefit Data; Data, Cost-Benefit; Cost Benefit |
Saturday, November 21, 2009
30 Oct 2009 
The Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST) completed randomization on July 18, 2008. Sponsored by the National Institute of Neurological Disorders and Stroke (NINDS), the trial has enrolled 2,522 participants across ... Read more...
A cost-effective screening method for preoperative hyperglycemia.
30 Oct 2009 INTRODUCTION: The preoperative encounter may offer a cost-effective opportunity for diabetes screening. METHODS: Three hundred forty-seven fasting patients had a preoperative glucose measurement determined from blood residue left on the IV needle, ... Read more...
Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt.
30 Oct 2009 BACKGROUND: The availability of rotavirus vaccines makes the implementation of a national immunization program an important decision requiring economic considerations. METHODS: A cost-benefit analysis of a national rotavirus immunization program in ... Read more...
Latest indexed articles for 'Cost-Benefit Analysis'
These are the very latest articles for this heading:
- The Carotid Revascularization Endarterectomy vs. Stenting Trial completes randomization: lessons learned and anticipated results. 30 Oct 2009
- A cost-effective screening method for preoperative hyperglycemia. 30 Oct 2009
- Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt. 30 Oct 2009
- Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya. 30 Oct 2009
- Rotavirus vaccines for infants in developing countries in Africa and Asia: considerations from a world health organization-sponsored consultation. 30 Oct 2009
- Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries. 30 Oct 2009
- Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan. 30 Oct 2009
- Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. 30 Oct 2009
- Cost-effectiveness of rotavirus vaccination in peru. 30 Oct 2009
- Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines. 30 Oct 2009
- Three-year cost analysis of function-centred versus pain-centred inpatient rehabilitation in patients with chronic non-specific low back pain. 30 Oct 2009
- Record number of infants immunised but 24 million in poor nations not being reached, says report.
19 Oct 2009 - Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States. 18 Oct 2009
- Summaries for patients. Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States. 18 Oct 2009
- A revealed preference approach to estimating supply curves for ecosystem services: use of auctions to set payments for soil erosion control in Indonesia. 18 Oct 2009
- [Walk-in spirometry pilot project for discovering of early chronic obstructive pulmonary disease] 17 Oct 2009
- Rehabilitation in patients admitted to intensive care. 14 Oct 2009
- The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial. 14 Oct 2009
- Potential cost-effectiveness of a rotavirus immunization program in rural China. 13 Oct 2009
- Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States. 13 Oct 2009
See a longer list of these articles.
Technical information about 'Cost-Benefit Analysis'
Definition: A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.
Descriptor UI: D003362
Alternative terms: Cost-Benefit Analysis; Analyses, Cost-Benefit; Analysis, Cost-Benefit; Cost-Benefit Analyses; Cost Benefit Analysis; Analyses, Cost Benefit; Analysis, Cost Benefit; Cost Benefit Analyses; Cost Effectiveness; Effectiveness, Cost; Cost-Benefit Data; Cost Benefit Data; Data, Cost-Benefit; Cost Benefit; Benefits and Costs; Costs and Benefits;
Allowable Qualifiers: classification; economics; history; legislation & jurisprudence; organization & administration; standards; trends; utilization; statistics & numerical data; ethics; methods;
Tree Number: N03.219.151.125;
History Note: 76
Technical Notes: NIM